Published in Neurology on July 13, 1999
Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms. Acta Neuropathol (2013) 2.30
Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias. J Med Genet (2003) 1.92
Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatry (2000) 1.87
SPG11 mutations are common in familial cases of complicated hereditary spastic paraplegia. Neurology (2008) 1.79
Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis. J Med Genet (2000) 1.50
Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am J Hum Genet (2003) 1.34
SPG11 spastic paraplegia. A new cause of juvenile parkinsonism. J Neurol (2009) 1.25
A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34. Am J Hum Genet (2000) 1.14
The Silver syndrome variant of hereditary spastic paraplegia maps to chromosome 11q12-q14, with evidence for genetic heterogeneity within this subtype. Am J Hum Genet (2001) 1.06
Spastic paraplegia with thin corpus callosum: description of 20 new families, refinement of the SPG11 locus, candidate gene analysis and evidence of genetic heterogeneity. Neurogenetics (2006) 1.00
A new locus for autosomal recessive spastic paraplegia associated with mental retardation and distal motor neuropathy, SPG14, maps to chromosome 3q27-q28. Am J Hum Genet (2000) 0.98
Troyer syndrome revisited. A clinical and radiological study of a complicated hereditary spastic paraplegia. J Neurol (2004) 0.97
SPG11: a consistent clinical phenotype in a family with homozygous spatacsin truncating mutation. Neurogenetics (2007) 0.88
"Pure" hereditary spastic paraplegias: the story becomes complicated. Neurology (1999) 0.86
Narrowing of the critical region in autosomal recessive spastic paraplegia linked to the SPG5 locus. Neurogenetics (2003) 0.80
Genetic mapping of a susceptibility locus for disc herniation and spastic paraplegia on 6q23.3-q24.1. J Med Genet (2002) 0.79
Patterns of Weakness, Classification of Motor Neuron Disease, and Clinical Diagnosis of Sporadic Amyotrophic Lateral Sclerosis. Neurol Clin (2015) 0.77
Chiari malformation type I associated with familial spastic paraplegia: report of a surgically treated case. Childs Nerv Syst (2004) 0.75
Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell (1987) 16.01
Engineered GFP as a vital reporter in plants. Curr Biol (1996) 9.03
Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ Mol Mutagen (2000) 6.24
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature (1989) 4.08
Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell (1988) 3.57
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology (2010) 3.37
Immunoelectron microscopic localization of dystrophin in myofibres. Nature (1988) 3.37
Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med (1993) 3.37
Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. J Cell Biol (2000) 3.34
ATP-linked calcium transport in cells and membrane vesicles of Streptococcus faecalis. J Biol Chem (1978) 3.14
Non-invasive quantitative detection and applications of non-toxic, S65T-type green fluorescent protein in living plants. Plant J (1999) 2.88
Videoendoscopic pulmonary lobectomy for cancer. Surg Laparosc Endosc (1992) 2.81
Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet (1991) 2.79
The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature (1988) 2.75
Lipids are required for directional pollen-tube growth. Nature (1998) 2.74
A proton-translocating ATPase regulates pH of the bacterial cytoplasm. J Biol Chem (1985) 2.71
Mutations in the integrin alpha7 gene cause congenital myopathy. Nat Genet (1998) 2.66
Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res (2000) 2.61
Regulation of the cytoplasmic pH in Streptococcus faecalis. J Biol Chem (1982) 2.61
Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infect Immun (1994) 2.60
Beta-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex. Nat Genet (1995) 2.53
Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology (2005) 2.53
Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med (1980) 2.50
"Joubert syndrome" revisited: key ocular motor signs with magnetic resonance imaging correlation. J Child Neurol (1997) 2.49
MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol (1992) 2.48
Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation. Neurology (2004) 2.48
Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci U S A (1994) 2.44
Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy. Lancet (1995) 2.40
Estimation of polyamine binding to macromolecules and ATP in bovine lymphocytes and rat liver. J Biol Chem (1991) 2.36
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33
Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann Neurol (2001) 2.29
Green-fluorescent protein as a new vital marker in plant cells. Plant J (1995) 2.28
Unique morphology of the human eye. Nature (1997) 2.27
Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J Natl Cancer Inst (1994) 2.25
Mutations in the CCN gene family member WISP3 cause progressive pseudorheumatoid dysplasia. Nat Genet (1999) 2.23
DNA methylation as a mechanism of transcriptional regulation in nonphotosynthetic plastids in plant cells. Proc Natl Acad Sci U S A (1988) 2.19
Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord (1992) 2.15
Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord (2009) 2.13
Immunohistochemical characterization of glomerular IgA deposits in IgA nephropathy. Clin Nephrol (1990) 2.09
Natural history study of hereditary multiple exostoses. Am J Med Genet (1995) 2.09
The number of ribosomal RNA genes in Mycoplasma capricolum. Mol Gen Genet (1981) 2.08
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology (2011) 2.06
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene (2000) 2.04
Streptococcal cytoplasmic pH is regulated by changes in amount and activity of a proton-translocating ATPase. J Biol Chem (1986) 2.03
Copper proteins and oxygen. Correlations between structure and function of the copper oxidases. J Gen Physiol (1965) 2.02
Lysenin, a novel sphingomyelin-specific binding protein. J Biol Chem (1998) 2.02
Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science (1990) 1.99
Familial skewed X inactivation: a molecular trait associated with high spontaneous-abortion rate maps to Xq28. Am J Hum Genet (1997) 1.99
Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol (2000) 1.99
Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. Am J Hum Genet (1998) 1.98
Inhibition of neurotransmission by peptides containing the synaptic protein interaction site of N-type Ca2+ channels. Neuron (1996) 1.98
Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol (1999) 1.95
The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle. Am J Hum Genet (1992) 1.94
Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res (1979) 1.93
A Met-to-Val mutation in the skeletal muscle Na+ channel alpha-subunit in hyperkalaemic periodic paralysis. Nature (1991) 1.92
Potential contribution of consumers to an integrated health care system. Public Health Rep (1976) 1.90
Public attitudes regarding willingness to participate in medical research studies. J Health Soc Policy (2000) 1.90
Field test of quantum key distribution in the Tokyo QKD Network. Opt Express (2011) 1.89
Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet (1997) 1.89
Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum Mol Genet (1995) 1.89
Amplification of the Streptococcus faecalis proton-translocating ATPase by a decrease in cytoplasmic pH. J Bacteriol (1984) 1.87
Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J Cell Biol (1990) 1.86
Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet (2000) 1.84
The incidence of simple renal cyst by computed tomography. Clin Radiol (1983) 1.82
Mutations in the sarcoglycan genes in patients with myopathy. N Engl J Med (1997) 1.82
Fetal disruptions: assessment of frequency, heterogeneity, and embryologic mechanisms in a population referred to a community-based stillbirth assessment program. Am J Med Genet (1990) 1.80
Consistent intergenic splicing and production of multiple transcripts between AML1 at 21q22 and unrelated genes at 3q26 in (3;21)(q26;q22) translocations. Proc Natl Acad Sci U S A (1994) 1.78
Genetic heterogeneity in families with hereditary multiple exostoses. Am J Hum Genet (1993) 1.77
Pressure-dependent metallic and superconducting phases in a germanium artificial metal. Phys Rev Lett (2009) 1.73
Cerebellar ataxia and coenzyme Q10 deficiency. Neurology (2003) 1.73
Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy. Ann Neurol (1994) 1.73
Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun (1994) 1.72
Actions of noradrenaline and acetylcholine on sympathetic ganglion cells. J Physiol (1970) 1.72
Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol (1984) 1.70
The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis (2014) 1.69
Clinical features of symptomatic Rathke's cleft cyst. Clin Neurol Neurosurg (2001) 1.68
Streptococcus faecalis mutants defective in regulation of cytoplasmic pH. J Bacteriol (1980) 1.67
Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemia. Leukemia Study Group of the Ministry of Health and Welfare (Kohseisho). Leukemia (1997) 1.66
Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension (1996) 1.65
Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem (1994) 1.64
Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics (1999) 1.64
Generation of slow postsynaptic potentials without increases in ionic conductance. Proc Natl Acad Sci U S A (1968) 1.62
Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy: evidence for failure of dystrophin production in dystrophin-competent myonuclei. Neurology (1995) 1.62
Heterogeneity and microtubule interaction of the CHO1 antigen, a mitosis-specific kinesin-like protein. Analysis of subdomains expressed in insect sf9 cells. J Cell Sci (1994) 1.61
Identification of a chromosome 6-encoded dystrophin-related protein. J Biol Chem (1990) 1.60
A recessive Arabidopsis mutant that grows photoautotrophically under salt stress shows enhanced active oxygen detoxification. Plant Cell (1999) 1.59
Establishment and characterization of a breast cancer cell line expressing Na+/I- symporters for radioiodide concentrator gene therapy. J Nucl Med (2000) 1.59
The frequency of patients with dystrophin abnormalities in a limb-girdle patient population. Neurology (1991) 1.59
Destruction of Xenopus cyclins A and B2, but not B1, requires binding to p34cdc2. EMBO J (1994) 1.59
Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification. Neurobiol Dis (2001) 1.59
Coexistence of the genes for putrescine transport protein and ornithine decarboxylase at 16 min on Escherichia coli chromosome. J Biol Chem (1991) 1.58
ATP-linked sodium transport in Streptococcus faecalis. II. Energy coupling in everted membrane vesicles. J Biol Chem (1980) 1.58
Retrospective study on PET-SPECT imaging in a large cohort of myotonic dystrophy type 1 patients. Neurol Sci (2010) 1.58
Primary adhalin deficiency as a cause of muscular dystrophy in patients with normal dystrophin. Ann Neurol (1995) 1.58
Genetic mapping and dominance of the amber suppressor, Su1 (supD), in Escherichia coli K-12. J Bacteriol (1970) 1.57
Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy. J Exp Med (1996) 1.56